797 related articles for article (PubMed ID: 10986126)
1. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
[TBL] [Abstract][Full Text] [Related]
2. High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMR.
Moy FJ; Chanda PK; Cosmi S; Pisano MR; Urbano C; Wilhelm J; Powers R
Biochemistry; 1998 Feb; 37(6):1495-504. PubMed ID: 9484219
[TBL] [Abstract][Full Text] [Related]
3. NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound.
Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Skotnicki JS; Wilhelm J; Powers R
Biochemistry; 1999 Jun; 38(22):7085-96. PubMed ID: 10353819
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
Nar H; Werle K; Bauer MM; Dollinger H; Jung B
J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
[TBL] [Abstract][Full Text] [Related]
6. High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy.
Moy FJ; Seddon AP; Böhlen P; Powers R
Biochemistry; 1996 Oct; 35(42):13552-61. PubMed ID: 8885834
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453.
Kohno T; Hochigai H; Yamashita E; Tsukihara T; Kanaoka M
Biochem Biophys Res Commun; 2006 May; 344(1):315-22. PubMed ID: 16603129
[TBL] [Abstract][Full Text] [Related]
8. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.
Kiyama R; Tamura Y; Watanabe F; Tsuzuki H; Ohtani M; Yodo M
J Med Chem; 1999 May; 42(10):1723-38. PubMed ID: 10346925
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for the highly selective inhibition of MMP-13.
Engel CK; Pirard B; Schimanski S; Kirsch R; Habermann J; Klingler O; Schlotte V; Weithmann KU; Wendt KU
Chem Biol; 2005 Feb; 12(2):181-9. PubMed ID: 15734645
[TBL] [Abstract][Full Text] [Related]
10. Structure of recombinant mouse collagenase-3 (MMP-13).
Botos I; Meyer E; Swanson SM; Lemaître V; Eeckhout Y; Meyer EF
J Mol Biol; 1999 Oct; 292(4):837-44. PubMed ID: 10525409
[TBL] [Abstract][Full Text] [Related]
11. Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1.
Zhang X; Gonnella NC; Koehn J; Pathak N; Ganu V; Melton R; Parker D; Hu SI; Nam KY
J Mol Biol; 2000 Aug; 301(2):513-24. PubMed ID: 10926524
[TBL] [Abstract][Full Text] [Related]
12. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.
Lang R; Kocourek A; Braun M; Tschesche H; Huber R; Bode W; Maskos K
J Mol Biol; 2001 Sep; 312(4):731-42. PubMed ID: 11575928
[TBL] [Abstract][Full Text] [Related]
13. Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor.
Feng Y; Likos JJ; Zhu L; Woodward H; Munie G; McDonald JJ; Stevens AM; Howard CP; De Crescenzo GA; Welsch D; Shieh HS; Stallings WC
Biochim Biophys Acta; 2002 Jul; 1598(1-2):10-23. PubMed ID: 12147339
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.
Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Chen L; Dunaway CM; Gu F; Mieling GE
J Med Chem; 1999 Jan; 42(1):87-94. PubMed ID: 9888835
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of Delta 5-3-ketosteroid isomerase complexed with the steroid 19-nortestosterone hemisuccinate.
Massiah MA; Abeygunawardana C; Gittis AG; Mildvan AS
Biochemistry; 1998 Oct; 37(42):14701-12. PubMed ID: 9778345
[TBL] [Abstract][Full Text] [Related]
16. High-resolution solution structure of the EGF-like domain of heregulin-alpha.
Jacobsen NE; Abadi N; Sliwkowski MX; Reilly D; Skelton NJ; Fairbrother WJ
Biochemistry; 1996 Mar; 35(11):3402-17. PubMed ID: 8639490
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of a sweet protein single-chain monellin determined by nuclear magnetic resonance and dynamical simulated annealing calculations.
Lee SY; Lee JH; Chang HJ; Cho JM; Jung JW; Lee W
Biochemistry; 1999 Feb; 38(8):2340-6. PubMed ID: 10029527
[TBL] [Abstract][Full Text] [Related]
18. The solution structure of bovine ferricytochrome b5 determined using heteronuclear NMR methods.
Muskett FW; Kelly GP; Whitford D
J Mol Biol; 1996 Apr; 258(1):172-89. PubMed ID: 8613986
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of the catalytic domain of gammadelta resolvase. Implications for the mechanism of catalysis.
Pan B; Maciejewski MW; Marintchev A; Mullen GP
J Mol Biol; 2001 Jul; 310(5):1089-107. PubMed ID: 11501998
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.
Van Doren SR; Kurochkin AV; Hu W; Ye QZ; Johnson LL; Hupe DJ; Zuiderweg ER
Protein Sci; 1995 Dec; 4(12):2487-98. PubMed ID: 8580839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
